Basic Information
Angion Biomedica Aims to Treat Kidney Diseases Including Acute Kidney Injury and Chronic Kidney Disease. The company's organ repair drugs are developed through rational drug design, targeting the body's protective, reparative, and regenerative systems to achieve therapeutic benefits, enabling patients to recover faster and thereby achieving better medical outcomes.
Angion Biomedica Corp.
Boston,Massachusetts,United States of America
101~500 people
January 01, 1998
mail@angion.com

